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Objectives. We investigated the treatment effects reported from a high-quality
randomized controlled trial of cognitive behavioural therapy (CBT) for 106 people with
borderline personality disorder attending community-based clinics in the UK National
Health Service – the BOSCOT trial. Specifically, we examined whether the amount of
therapy and therapist competence had an impact on our primary outcome, the number of
suicidal acts†, using instrumental variables regression modelling.
Design. Randomized controlled trial. Participants from across three sites (London,
Glasgow, andAyrshire/Arran) were randomized equally toCBT for personality disorders
(CBTpd) plus Treatment as Usual or to Treatment as Usual. Treatment as Usual varied
between sites and individuals, but was consistent with routine treatment in the UK
National Health Service at the time. CBTpd comprised an average 16 sessions (range
0–35) over 12 months.
Method. Weused instrumental variable regression modelling to estimate the impact of
quantity and quality of therapy received (recording activities and behaviours that took
*Correspondence should be addressed to Kate Davidson, Institute of Health & Wellbeing, Admin Building, Gartnavel Royal
Hospital, 1055 Great Western Road, Glasgow G12 0XH, UK (e-mail: Kate.Davidson@glasgow.ac.uk).
†Suicidal act: A suicidal act meets all three of the following criteria: (1) Deliberate (i.e., not be construed as an accident, planning
involved, and the individual accepts ownership of the act); (2) life threatening, in that the individual’s life was deemed to be
seriously at risk, or he or she thought it to be at risk, as a consequence of the act; and (3) the act resulted in medical intervention or
intervention would have been warranted. The individual may have sought or would have warranted medical intervention or
medical intervention was sought on their behalf. Medical intervention need not be treatment, but at the minimum a physical
examination is implied.
NIH Clinical Trials Gov Identifier: NCT00538135.
DOI:10.1111/papt.12004
280
place after randomization) on number of suicidal acts and inpatient psychiatric
hospitalization.
Results. A total of 101 participants provided full outcome data at 2 years post
randomization. The previously reported intention-to-treat (ITT) results showed on
average a reduction of 0.91 (95% confidence interval 0.15–1.67) suicidal acts over 2 years
for those randomized to CBT. By incorporating the influence of quantity of therapy and
therapist competence, we show that this estimate of the effect of CBTpd could be
approximately two to three times greater for those receiving the right amount of therapy
from a competent therapist.
Conclusions. Trials should routinely control for and collect data on both quantity of
therapy and therapist competence, which can be used, via instrumental variable
regression modelling, to estimate treatment effects for optimal delivery of therapy. Such
estimates complement rather than replace the ITT results, which are properly the
principal analysis results from such trials.
Practitioner points
 Assessing the impact of the quantity and quality of therapy (competence of therapists)
is complex.
 More competent therapists, trained in CBTpd, may significantly reduce the number of
suicidal acts in patients with borderline personality disorder.
We investigated the estimated treatment effects from the BOSCOT randomized controlled
trial of cognitive behavioural therapy for personality disorders (CBTpd) in addition to
treatment as usual (CBTpd plus TAU) compared with TAU alone in 106 people with
borderline personality disorder (Davidson, Norrie et al., 2006; Davidson, Tyrer et al.,
2006). Those results used intention-to-treat (ITT) principle, recognized as the appropriate
methodology for the principal reporting of randomized controlled trials. The additional
analyses presented here go beyond these results and utilize information on quantity and
quality of therapy received (recording activities and behaviours that took place after
randomization), relating this information to two of our primary outcomes, suicidal acts
and inpatient hospitalization, using instrumental variable regression modelling. In
addition, we investigate any possible delay in the treatment effect manifesting itself,
sometimes a feature of complex interventions such as CBT (Medical Research Council,
2000, 2008). These additional analyses are important to patients and clinicians as they
provide an estimate of the benefit CBTpd would give under ideal conditions. They also
inform comparisons of different psychological therapies when resources are scarce and
may help identify subgroups of patients who may benefit most from therapy.
Method
The BOSCOT study design (Davidson, Tyrer et al., 2006), results (Davidson, Norrie et al.,
2006), and economic implications (Palmer et al., 2006) have been reported elsewhere. In
brief, patients in both treatment arms showed gradual and sustained improvement in both
primary and secondary outcomes, with evidence to show that addition of CBTpd
benefited the positive symptom distress index at 1 year, and state anxiety, dysfunctional
beliefs, and the quantity of suicidal acts over the 2-year study period. We subsequently
reported on the 6-year follow-up of this randomized cohort (Davidson, Tyrer, Norrie,
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Palmer, & Tyrer, 2010) – the analyses presented here do not include this longer term
follow-up as we do not have correspondingly high quality (in terms of completeness and
accuracy) of therapy received in the years 3–6 after the completion of the randomized trial
follow-up.
Nearly all 106 participants randomized had primary and secondary outcome data at 6,
12, 18, and 24 months. These additional analyses on how quantity and quality of CBT
might influence behaviour and inpatient hospitalization are therefore not complicated by
missing outcome data. In addition, BOSCOT had no ‘treatment crossovers’, as the form of
CBT for personality disorders specified in the therapy protocol differs considerably from
conventional CBT for Axis I disorders (Davidson, 2007), and was not available in the NHS
during the study period.
Therapist competence
Any psychological therapy will have some variability in terms of quality of delivery. CBT
therapists vary in their degree of skill, and some will become better (or worse) as they
become more experienced. Quality of therapy in CBT trials comprises at least two
dimensions: the therapeutic alliance and the competencewithwhich therapy is delivered.
Therapeutic alliance is the specific working relationship that develops between a
patient and therapist. Competence of the therapist in delivering CBTpd is the focus here.
A therapist’s competence involves his/her understanding of the patient’s problems, the
appropriateness of an intervention or use of techniques, and the therapist’s aptitude at
delivering interventions in a skilled manner.
Wemeasured therapist competence using the BOSCOT Rating Scale (Davidson, 2007)
and the Cognitive Therapy Rating Scale (CTRS; Young & Beck, 1990). All five BOSCOT
therapists submittedCBTpd session audiotapes. A randomselectionof audiotapes from24
of the 38 patients (73% of the 54 patients randomized to CBTpd), who gave written
consent to their sessions being recorded, were rated by two experienced clinical
psychologists (KD and AG), both blind to treatment outcome, and established good inter-
rater agreement on therapist competence (see Davidson, Norrie et al., 2006). Data on
how often and when CBTpd sessions were offered, declined, and attended, were
collected, allowing characterization of therapy delivery in terms of therapist competence
and frequency and intensity of therapy sessions.
Is there a time lag for treatment effect on suicidal behaviour? Any interventionmay take
time for an effect to manifest itself. After randomization to CBTpd, it might take several
weeks for the first appointment to be scheduled, due to the practical constraints of
delivering the service. It seems reasonable that a ‘treatment effect’ would not be seen
before treatment has been received. In addition, itmay also take several sessions to engage
patients and develop a collaborative therapeutic relationship, which will permit the
implementation of specific cognitive behavioural techniques. Even after therapy
commences, it may take several sessions for any therapeutic effect to accumulate as
techniques become practised and implemented. We therefore discounted the earliest
suicidal acts as being unlikely to have been influenced by therapy, which either was yet to
start, or had only recently begun.
Statistical methods
There are three parts to the analyses. (1) time lag of a treatment effect; (2) the inter-
relationships between quality (therapist competence) and quantity (number of sessions
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attended) of therapy, and outcomes; and (3) instrumental variable regression to
investigate the influence of quantity and quality of therapy on outcome, for which Stata
10.0SE was used. All other analyses used SAS 9.2 for Windows. No adjustment was made
for multiple comparisons as we judged that the risk of making a Type I error was offset by
the importance of these post-randomization analyses to the development of improved
understanding of the interactions between characteristics of therapy delivered in the
context of clinical trials and the primary outcomes of these trials.
(1) The time lag of treatment effect analyses used standard ITT statistical techniques,
with the ‘time zero’ moved forward incrementally by 30, 60, 90, and 180 days, so
deleting all suicidal events that happened before these milestones. For the
corresponding analysis on inpatient hospitalizations (IPH), we restricted these to
the first 6 months as this was most likely to be accurately reported and case notes
were checked.
(2) For analyses of associations between intervention characteristics (sessions offered,
attended, cancelled, and ‘did not attend’, and delay from randomization to first
session, duration of sessions [elapsed time from first to last session attended], and
intensity of sessions [sessions attended per 3-month period]), we grouped variates
above or below their medians and then performed two sample t-tests on the other
variates of interest. For linear models of predictors of intensity, we used stepwise
regression with p-to-enter and p-to-stay both .10, and indicator variables to adjust
for therapist forced into the model.
(3) For the analyses adjusting outcome for quantity and quality of therapy, we used
ComplierAveragedCausal Effectsmodels, as describedbyDunnandBentall (2007),
Dunn et al. (2003) and Dunn, Maracy, and Tomenson (2005), as implemented in
the two-stage least-squares routine ‘ivregress’ in Stata 10.0SE. We present three
estimates: (1) unadjusted; (2) adjusted for four baseline factors strongly associated
with outcome, whichwas the number of suicidal acts – these baseline factors were
number of suicidal acts in the 12 months before randomization, being single, age at
first deliberate self-harm, and EQ-5D score at baseline; and (3) the interaction of
treatment with each of these four baseline predictors to check whether the
exclusion restriction (see below) was likely to hold in this data set.
Results
Outcome of time lag for treatment effects on suicidal behaviour analyses
From themain results paper, visual examination suggested that the time to first suicidal act
curves are initially coincident and only separated and diverged after about 6 months
(figure 1A, Davidson, Norrie et al., 2006). To investigate whether this could indicate a
delayed onset of a treatment effect, Figure 1 is the corresponding Kaplan–Meier curve
after excluding events before 182 days after randomization. There is no support for a
delayed treatment effect. To understand this, we observe that approximately half the
participants have no event over 24 months, about a quarter have one event, and the other
quarter more than one suicidal act. So, the main effect of excluding the first 6 months of
follow-up data is to simply delay the time at which a multiple-suicide-act participant will
have a first suicidal act In the original analysis; 26 TAU against 23 CBTpd had at least one
suicidal act, log-rank p = .29. Omitting any events in the first 30 days gives 26 versus 22,
log-rank p = .33; omitting the first 60 days gives 24 versus 21, log-rank p = .46; omitting
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the first 90 days gives 23 versus 20, p = .44; and omitting the first 6 months gives 17
versus 16, log-rank p = .97. For suicidal acts, the ITT analysis gave a 24-month mean of
1.73 (SD 3.11) on TAU and 0.87 (1.47) onCBTpd + TAU – an adjusted difference of0.91
(95% confidence interval 1.67 to 0.15, p = .020). Omitting the first 180 days, the
corresponding estimates are 1.31 (2.73) and 0.42 (0.87), with an adjusted difference of
0.86 (95% CI 1.51 to 0.20, p = .010). That is, there is very little difference between
the two analyses.
A similar analysis for inpatient psychiatric hospitalizations (IPH) excluded events
within the first 182 days after randomization. The numbers of participants with at least
one IPH falls from the original 23 (47%) for TAU to 18 (34%) comparedwithCBTpd rates of
12 (24%) and 14 (27%), respectively, over the remaining 18 months. Interestingly, then,
the event rate is much higher in the first 6 months (Figure 2). Therefore, for IPH, the
reverse may be true – a treatment effect that manifests early and then disappears, which
may be a quite common phenomenon seen across a variety of therapeutic interventions.
A post-hoc Cox regression analysis for IPH (adjusting for the pre-specified covariates
used in the original ITT analyses) shows a significant benefit in favour of CBTpd + TAU
over TAU: 18 (37%) on TAU had at least one IPH compared with 12 (24%) on
CBTpd + TAU, adjusted hazard ratio 0.41 (95% CI 0.18–0.93, p = .032). However, care
should be taken not to overinterpret this finding as the numbers are small and this is a data-
driven post-hoc comparison.
Inter-relationships between quantity and quality of therapy and outcomes
It is important to understand the inter-relationships between the quality and quantity of
therapy, and outcomes, and what baseline data might help predict these, to aid
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Figure 2. Time to first Inpatient hospitalization – in the first 180 days.
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Figure 1. Time to first suicidal act, omitting the first 180 days post randomization.
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interpretation of the instrumental variables regression models that adjust the treatment
effects for these characteristics of the therapy.
We have previously reported uptake of CBTpd sessions and therapist competence
according to the CTRS and a specific rating scale developed by the author for CBT for
personality disorder – the BOSCOT Rating scale. Figure 3 gives the boxplots of
descriptive statistics for the CTRS by therapist (very similar results were seen for the
BOSCOT Rating Scale). These boxplots indicate that there is substantial variability in the
ratings both within and between therapists.
Table 1 gives further information onCBTpdquantity, reporting session characteristics
by therapist. There is considerable variability across therapists in all the measures of
CBTpd sessions – offered, attended, cancelled, and ‘did not attend’. Not surprisingly,
sessions attended is highly significantly associated with number of sessions offered, with
an additional eight attended for every 10 offered (p < .0001). Sessions cancelled is
significantly associated with sessions offered, with approximately every 10 additional
sessions offered likely to result in one additional cancellation (p = .039).
The number of ‘did not attends’ was not associated with sessions offered (p = .41),
which may indicate that once patients have low engagement in therapy, this persists
despite therapists attempts to re-engage them. In addition, delay in initiating treatment
(time elapsed from randomization to first session attended, excluding thosewho attended
no sessions) in 40 of 54 subjects in the CBTpd group with data averaged 43 days (SD 33;
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Figure 3. Boxplots of Cognitive Therapist Rating Scale by Therapist. Data shown are minimum and
maximum (dotted box), interquartile range (yellow box), median (solid dot), and mean (open dot).
Table 1. Details of cognitive behavioural therapy sessions (mean [standard deviation]) offered,
attended, cancelled, and did not attend
Therapist (number of patients) Offered Attended Cancelled Did not attend
A (20) 24 (11) 14 (12) 3 (3) 8 (7)
B (5) 35 (13) 14 (13) 4 (5) 17 (12)
C (13) 31 (11) 21 (12) 4 (4) 7 (5)
D (3) 47 (3) 20 (1) 2 (3) 24 (2)
E (11) 22 (12) 18 (13) 2 (2) 2 (3)
Overall (52) 27 (13) 17 (12) 3 (3) 8 (8)
Influence of therapist competence and quantity of CBT 285
median 33; range 19–123 days). Duration of treatment (time between first and last CBTpd
sessions) was 350 days (SD 173; median 386, range 1–574 days). Intensity of therapy
(sessions attended/duration of therapy, per 3 months, for 35 participants with data)
averaged 4.81 (SD 3.22; median 5.05; range 0.68–20.1 CBTpd sessions/3 months).
Relationship between quality and quantity of therapy and session characteristics
More ‘did not attends’ (>5)were associatedwith a significantly lower scores on theCTRS –
14 points lower than the group with 5 or less DNAs (95% CI 3–25, p = .014). Otherwise,
there was little association between any other measures – sessions attended and sessions
cancelled – albeit with non-significant trends in the expected direction – nor delay to
initiation of therapy, duration, or intensity of therapy. Sessions cancelled (three sessions/
quarter more, approximately 95% 1–5, p = .0091) and DNA (seven extra sessions,
approximately 95% CI 4–11, p = .0004) are both significantly lower among subjects with
a higher intensity of therapy (>5 sessions/quarter). Likewise, a higher intensity of therapy
is associated with a shorter delay in initiating therapy (26 days, 95% CI 0–53, p = .047).
Relationship of outcome with quantity and quality of therapy
Figure 4 shows the mean number of suicidal acts (in the previous 6-month period) by
treatment group across 12 months of treatment and 12 months of follow-up. Figure 5
relates suicidal acts over the 12-month period of therapy to the quantity of CBTpd and
likewise Figure 6 shows quality of CBTpd (ranking therapists by their average CTRS
score). From Figure 5, although the baseline rate is higher than the treated rate across the
board, there is no indication of an obvious, simple relationship between treatment
received and treatment effect. Indeed, the lowest rate of suicidal acts post randomization
(0.1/year) is among those with fewest CBTpd sessions, and the highest among those who
received the most. However, in our design, participants were not randomized to
therapists and it might be the case that some therapists had easier, or more difficult
patients, or that those who needed the least CBTpd actually took the least number of
sessions of CBTpd, while those who neededmost received the largest amount of therapy.
We have therefore added the expected rate from the stepwise baseline predictive model
(Table 2).
Although much of the difference between low and high session attendance can be
explained by client type (0.25 suicide acts expected for 0–4 sessions attended through to
0.64 for 30+ sessions attended), there is still an indication that those receiving less therapy
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Figure 4. Mean number of suicidal acts (in the previous 6-month period) by randomized treatment
group.
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did proportionately better than would have been expected. For therapist competence, a
similar picture emerges: apparently, the least competent therapist gets better results, and
that coming from a position of highest average baseline suicidal acts. Considering the
expected number of suicidal acts, the picture is less clear – it is the ‘best’ and the ‘worst’
therapists who exceed expectations, while the middle ranked therapists in terms of
competence have higher numbers of ‘observed’ as opposed to ‘expected’ suicidal acts.
Base Treated: observed Treated : expected
3.5
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Figure 5. Suicidal acts per year by number of sessions taken.
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Figure 6. Suicidal acts per year by therapist competence.
Table 2. Baseline predictors of quantity (number of sessions) and quality (Cognitive Therapy Rating
Scale), using data only from those randomized to cognitive behavioural therapy for personality disorders
plus treatment as usual (TAU)
Baseline predictor
Quality – Cognitive
Rating Scale
Estimate (SE) p-Value
Quantity – number
of sessions
Estimate (SE) p-Value
Age at randomization
(5 years)
2.79 (0.78) .0008
Age at first Deliberate
Self-Harm (5 years)
7.00 (1.73) .0007
Female 14.9 (5.04) .0087
EQ-5D (0.1 units) 2.91 (0.64) .15
Young’s Schema
Quest (total)
7.81 (3.02) .018 6.83 (2.13) .0023
Note. Stepwise model only. Data shown are the estimated change in number of suicidal acts (standard
error of estimate) with associated p-value.
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Baseline predictors of quality and quantity of therapy
Using similar methodology as we did for the baseline predictors of outcome model,
Table 2 shows that lower age at first deliberate self-harm episode and being female predict
higher CTRS score, while higher quality of life and higher score on the Young Schema
Questionnaire predict lower CTRS score. For number of sessions attended, older age
predicts more sessions, while higher scores on the Young SchemaQuestionnaire predicts
fewer sessions. Table 3 gives the rank correlations between all the baseline predictors and
quality and quantity of therapy, and also outcome.
Instrumental variable regression modelling of treatment effects
To summarize, we have explored the data on quality and quantity of therapy, and
informally associated these data with the outcome of number of suicidal acts. We have
seen that linking measures of quality and quantity of therapy to outcomes is difficult as
these are not baseline measures equalized by randomization and temporally measured
before any outcomes of interest. Fortunately, there has been much development in the
statistical methodology in the last decade to robustly incorporate such post-randomi-
zation data assessing the ‘success’ in delivering intervention and outcomes. Broadly, the
idea is to identify participants who, in some sense, had the best chance of responding,
and then the magnitude of their response indicates what treatment benefit may be
achieved if we were to optimize the delivery of the intervention to the right recipients.
The Complier-Average Causal Effect, or CACE estimate, introduced by Angrist, Imbens,
and Rubin (1996) and discussed by Bellamy, Lin, and Ten Have (2007), Dunn and Bentall
(2007) and Dunn et al. (2003, 2005), is an attractive methodology for this task,
identifying a group of ‘compliant’ participants before randomization, who are then
Table 3. Spearman rank correlations of baseline covariates with (1) quantity (number of sessions); (2)
quality (Cognitive Therapy Rating Scale); and (3) outcome (number of suicidal acts over 2 years post
randomization)
Baseline predictor
Quantity
(sessions)
N = 54
Quality
(CT rating)
N = 26
Outcome
(suicidal acts)
N = 54
# Suicidal acts in last 12 months .14 .17 .51a
Age at randomization (5 years) .06 .07 .42c
Age at first Delib Self-Harm (5 years) .39c .04 .05
High Self-harm .17 .45d .14
Female .17 .08 .17
Single .23 .17 .21
Left School < 16 .13 .01 .28d
Special Needs .11 .14 .08
Lives Alone .20 .13 .17
Crime in last 12 months .16 .14 .07
Unemployed .17 .12 .02
EQ-5D (0.1 units) .18 .22 .03
Young’s Schema Quest (total) .35d .41d .19
Note. The Spearman rank correlation between quality and quantity of therapy is .30, between quality and
outcome .18, and between quantity and outcome .16.
ap < .0001; bp < .001, cp < .01, dp < .05.
288 John Norrie et al.
equally distributed by randomization across the groups. The model then compares the
observed behaviour of the compliers in the treatment group with what would have been
observed if this group had been randomized to the other group. All of these so-called
instrumental variable regression models rest heavily on assumptions that cannot be
verified objectively.
For CACE models, an important assumption is the ‘exclusion restriction’ – the
assumption that the randomization itself does not influence the outcome: for example, a
participant who wanted to get CBTpd and was randomized to TAU does not suffer
‘resentful demoralisation’, which then worsens their outcomes (Torgerson & Sibbald,
1998a, 1998b). We tested whether the exclusion restriction held by including the
interaction of treatment with each of the important baseline factors strongly associated
with outcome (i.e., baseline number of suicidal acts in the previous 12 months, being
single, age at first deliberate self-harm, and the EQ-5D score prior to randomization).
Table 4 gives the CACE model results for (1) quality of CBTpd therapy (CTRS score
 60 vs. <60); and (2) quantity of therapy (sessions attended  15 vs. <15). In both cases,
the treatment effect approximately doubles, with the ITT of 0.91 saved suicidal acts
becoming1.93 for the high-quality CBTpd and2.17 for the higher number of sessions.
Note that the confidence intervals around the estimates are wider, and note further that it
is only after adjusting for baseline suicidal acts (in the previous 12 months before
randomization), age at first deliberate self-harm, singlemarital status, and EQ-5D quality of
life scores that these estimates reach statistical significance.
Figure 7 gives a visual depiction of the interesting feature that there may be a
qualitative interaction between quality and quantity of therapy, with the largest
reductions coming from those who had the more competently delivered therapy, but
in limited quantity. To investigate this, we combined these two variables to create the
Table 4. Results of Complier-Average Causal Effect modelling
Model Description CBT-TAU (95% CI) p-Value
Full (ITT) Full (ITT) 0.91 (1.67, 0.15) .020
More competent (>60) Unadjusted 1.52 (3.17, 0.13) .070
Adjusteda 1.93 (3.19, 0.67) .003
Fully instrumentedb 2.05 (3.31, 0.80) .001
Quantity (>15) Unadjusted 1.63 (3.49, 0.23) .085
Adjusteda 2.17 (3.79, 0.56) .008
Fully instrumentedb 1.43 (2.85, 0.01) .048
More competent + quantity (<15) Unadjusted 2.85 (6.04, 0.34) .079
Adjusteda 3.35 (5.64, 1.07) .004
Fully instrumentedb 3.97 (6.12, 1.84) <.001
More competent + quantity (3–20) Unadjusted 4.14 (9.09, 0.79) .10
Adjusteda 4.73 (8.25, 1.22) .008
Fully instrumentedb 5.94 (9.28, 2.61) <.001
Note. CBT, cognitive behavioural therapy; ITT, intention-to-treat.
aModels adjusted for baseline suicidal acts, singleness, age at first deliberate self-harm, and EQ-5D quality-
of-life score.
bModel is as for adjustedmodel including baseline suicidal acts, singleness, age at first deliberate self-harm,
and EQ-5D quality-of-life score, but now the interaction of treatment with each of these factors is
included as additional instruments to check the exclusion restriction assumption.
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subgroup, which had more competently delivered therapy (a therapist with an average
score onCTRS  60), but attended <15 sessions. The treatment estimate nowchanges to
3.35 suicidal acts averted every 2 years. We went one stage further and redefined the
quantity as being between 3 and 20, so removing those who had so little therapy
(including none) that it was difficult to see how benefit could have derived, and adding in
some participants with a few more sessions (from 16 to 20). The CBTpd treatment
estimate now rose to almost five suicidal acts averted.
For each model, we also give the ‘fully instrumented’ version, which includes the
interaction of quality and quantity of treatment with the four baseline predictors. In all
cases, the model holds, indicating that there is little or no evidence that the exclusion
restriction is invalid here. By using these additional instruments, the IV estimate of the
quantity and quality of therapy increase a bit and are more precisely estimated.
Discussion
These further analyses allow some dismantling of the previously reported ITT analyses
(Davidson, Norrie et al., 2006) and suggest a relationship between the quantity and
quality of therapy received and suicidal behaviour. Specifically, using CACE models, we
find the ITT treatment estimate of approximately one suicidal act averted over 2 years
approximately doubles when treated by more competent therapists and when in receipt
of over 15 therapy sessions. Intriguingly, there was an indication of a qualitative
interaction between quantity and quality, with a treatment effect of approximately three
suicidal acts averted (over triple the ITT estimate) for those receiving a limited amount of
therapy (<15 sessions) from a competent therapist.
The investigation of a possible time lag in the treatment effect of CBTpd led to
discovering an effect for inpatient hospitalization in the first 6 months only. The finding
might indicate that because hospitalization often follows severe, acute self-harm
behaviour, CBTpd may have a short-term effect in averting such behaviour, but it may
not have a longer term effect, in contrast to the hypothesized longer term delayed
treatment effect investigated for CBTpd for suicidal behaviour. This finding should be
considered cautiously, however, as number of inpatient hospitalizations were low and
this was a purely post-hoc analysis.
These findings underscore the importance of examining the effect of therapist
competence and amount of therapy that may be required to improve adverse outcomes.
Therapists competent in CBTpd can deliver change in patient’s suicidal behaviour in 20 or
fewer sessions over 1 year, and this effect remained throughout the 2-year period. This is
in contrast to the majority of studies of psychological therapy that offer highly intensive
and lengthy treatment regimens (e.g., Bateman& Fonagy, 1999; Giesen-Bloo et al., 2006).
Our findings suggest that the precise length of therapy offered should be evaluated more
rigorously.
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Figure 7. Suicidal acts by therapist competence and sessions attended.
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These additional analyses raise interesting and complex methodological issues.
Intention-to-treat analysis is preferred over other approaches (such as analysing the data
by groups defined by what intervention was actually received) for the primary analysis of
efficacy outcomes. However, participants do not receive their randomized intervention
in a perfectly uniform and prescribed manner, nor do they return perfect data on all
outcomes measured at all times and routinely in trials (White, 2005). Such departures
from the ideal result in different (statistical) analytic approaches yielding different – and
sometimes very different – estimates of treatment effects. The more non-compliance
with randomized intervention, the more major protocol deviation, the more loss to
follow-up, and so on, the larger the potential discrepancy between the various analyses
might become. As the magnitude of these factors increases, the quality of the evidence
decreases, and there is no panacea for the analysis of poor-quality data – all the analyses,
including ITT, will be potentially misleading given poor data. Fortunately in BOSCOT, the
quality of data was high with minimal loss to follow-up, and in addition, no complication
of treatment crossovers. Also, we measured several ‘process variables’ related to the
quality and quantity of therapy, and in this study, having explored the associations
between these process variables and both baseline and outcome data, we then used
formal CACE modelling to investigate what treatment effect appears to have been
enjoyed by those that received the more competently delivered therapy in the
appropriate quantity.
The ITT analysis addresses the issue of what benefit might accrue from the offer of
one type of management over another, whereas the instrumental variables analysis tries
to assess what the benefit for a subgroup who actually receive, in some sense,
‘optimized therapy’. Both analyses are therefore of value – the ITT analysis gives
unbiased, rigorous scientific evidence of whether the intervention is likely to be of
benefit. If the ITT analysis indicates likely benefit, then the instrumental variable
regression analysis can estimate this benefit under ideal conditions, which is of interest
to clinicians and patients and in addition can be helpful when comparing different
psychological therapies when resources are scarce and for identifying subgroups of
patients who may benefit most.
There are, however, some limitations. First, despite the high-quality data, at 106
participants, this trial is quite small, albeit large for a study of borderline personality
disorder. Furthermore, our estimates of therapist competence were based on only a
subset of all the sessions undertaken, and on a random sample of only 24 of the 54
patients randomized to CBTpd. Not all patients agreed to have their CBT sessions
recorded, and not all of the sessions taped were sufficiently audible to rate. In addition,
participants were not randomly allocated to therapists, which would have made many of
the analyses we have undertaken conceptually easier. Although all therapists were
trained in CBTpd for borderline personality disorder and received weekly supervision,
the robustness of the trial would have been enhanced if they had been trained and then
evaluated as being at or above a threshold of competency before the trial began. In a
pragmatic trial, we accepted that therapists would vary in their degree of competence in
delivering CBTpd. As well as having competence ratings for all the trial sessions (albeit a
prohibitive amount of work), it may have been useful to have additional competence
ratings for each therapist presented with the same clients (who were not randomized
into the study). Such measures of competence could have then been considered as
genuine baseline covariates.
In conclusion, we have supplemented the reporting of the BOSCOT trial with this
article, following the design and baseline characteristics (Davidson, Tyrer et al., 2006),
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the ITT results (Davidson, Norrie et al., 2006), and the economic evaluation (Palmer
et al., 2006), and the 6-year follow-up analyses (Davidson et al., 2010). We have shown
that if competently delivered therapy is given in the right quantity, patients can derive
substantial benefit. Future trials of CBT should explore the effect of quantity and of quality
of therapy on outcome.
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